Jialal et al. [31] recently showed in subjects with MetS (n = 36) compared to age- and gender-matched controls (n = 38) that there was a significant reduction of 83% in granulocyte colony-stimulating factor levels in patients with MetS. Here, CSF3 is linked to metabolic syndrome.